- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HIV vaccine research in Canada ; volume:14 ; number:1 ; day:12 ; month:9 ; year:2017 ; pages:1-3 ; date:12.2017
AIDS research and therapy ; 14, Heft 1 (12.9.2017), 1-3, 12.2017
- Keyword
-
Allergie
Immunkrankheit
- Creator
-
Shattock, Robin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-017-0181-8
- URN
-
urn:nbn:de:1111-201711109724
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shattock, Robin
- SpringerLink (Online service)
Other Objects (12)
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
HIV prevention by vaccine
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative
Prospecting for an HIV vaccine
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Nanoparticles for HIV-1 vaccine delivery
Is an HIV vaccine achievable? - Pros
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
HIV prevention by vaccine
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative
Prospecting for an HIV vaccine
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Nanoparticles for HIV-1 vaccine delivery
Is an HIV vaccine achievable? - Pros
Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
HIV prevention by vaccine
Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada
Correction to: Under consent: participation of people with HIV in an Ebola vaccine trial in Canada
Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative
Prospecting for an HIV vaccine
Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)
P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Nanoparticles for HIV-1 vaccine delivery